PS Ratio Chart

Historical PS Ratio Data

View and export this data back to 1998. Start Trial.
Date Value
October 23, 2026 6.391
October 22, 2026 6.438
October 21, 2026 6.290
October 20, 2026 6.410
October 19, 2026 6.269
October 16, 2026 6.397
October 15, 2026 6.446
October 14, 2026 6.289
October 13, 2026 6.058
October 12, 2026 6.161
October 09, 2026 6.192
October 08, 2026 6.025
October 07, 2026 6.015
October 06, 2026 5.907
October 05, 2026 5.924
October 02, 2026 5.928
October 01, 2026 6.041
September 30, 2026 6.105
September 29, 2026 6.196
September 28, 2026 6.234
September 25, 2026 6.182
September 24, 2026 6.131
September 23, 2026 6.200
September 22, 2026 6.253
September 21, 2026 6.166
Date Value
September 18, 2026 6.148
September 17, 2026 6.18
September 16, 2026 6.049
September 15, 2026 5.992
September 14, 2026 5.997
September 11, 2026 5.886
September 10, 2026 5.931
September 09, 2026 5.965
September 08, 2026 6.006
September 04, 2026 6.184
September 03, 2026 6.194
September 02, 2026 6.128
September 01, 2026 6.140
August 31, 2026 5.994
August 28, 2026 5.967
August 27, 2026 6.097
August 26, 2026 6.065
August 25, 2026 6.093
August 24, 2026 6.010
August 21, 2026 5.985
August 20, 2026 5.875
August 19, 2026 6.045
August 18, 2026 5.875
August 17, 2026 5.690
August 14, 2026 5.667

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
AbbVie, Inc. 7.865
Vertex Pharmaceuticals, Inc. 10.57
Amgen, Inc. 6.246
Biogen, Inc. 3.833
Johnson & Johnson 6.488

PS Ratio Related Metrics